Open AccessNovel Dual-Targeting Antibody Fragment IDB0062 Overcomes Anti–Vascular Endothelial Growth Factor Drug Limitations in Age-Related Macular Degeneration
Author(s) -
Seongbeom Kim,
Gihong Min,
Bomin Kim,
Do-Seop Lee,
Myongjae Lee,
Jong-Hee Ko,
Hyuk-Sang Kwon
Publication year - 2021
Publication title -
translational vision science and technology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 21
ISSN - 2164-2591
DOI - 10.1167/tvst.10.14.35
Subject(s) - macular degeneration , vascular endothelial growth factor , aflibercept , ranibizumab , placental growth factor , growth factor , medicine , choroidal neovascularization , pharmacology , vascular endothelial growth factor a , in vivo , angiogenesis , cancer research , bevacizumab , biology , ophthalmology , receptor , microbiology and biotechnology , chemotherapy , vegf receptors
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom